Literature DB >> 3148139

The effects of scopolamine on working memory in healthy young volunteers.

J M Rusted1, D M Warburton.   

Abstract

Twenty healthy young adults completed a series of nonverbal and problem solving tasks in a repeated measures design involving placebo and 0.6 mg scopolamine, administered by subcutaneous injection. Subjects completed the test battery under standard presentation conditions and with concurrent articulation, which precludes verbal recoding of test material. Under standard presentation conditions, scopolamine significantly impaired performance on the problem solving task and on tasks of visuo-spatial and spatial memory; memory for abstract shapes was not impaired. Concurrent articulation impaired performance on the shape recognition and interacted with drug treatment on the problem solving task. The results suggest that scopolamine impairs working memory, and that the decrement is at the level of the central executive mechanisms rather than the subsystems which it controls.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3148139     DOI: 10.1007/bf00177553

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  15 in total

1.  Dementia and working memory.

Authors:  A Baddeley; R Logie; S Bressi; S Della Sala; H Spinnler
Journal:  Q J Exp Psychol A       Date:  1986-11

2.  Human memory and the cholinergic system. A relationship to aging?

Authors:  D A Drachman; J Leavitt
Journal:  Arch Neurol       Date:  1974-02

Review 3.  The cholinergic neurotransmitter system in human memory and dementia: a review.

Authors:  M D Kopelman
Journal:  Q J Exp Psychol A       Date:  1986-11

4.  The effects of intravenous diazepam and hyoscine upon human memory.

Authors:  C D Frith; J T Richardson; M Samuel; T J Crow; P J McKenna
Journal:  Q J Exp Psychol A       Date:  1984-02

5.  The effects of scopolamine upon verbal memory: evidence for an attentional hypothesis.

Authors:  M P Dunne; L R Hartley
Journal:  Acta Psychol (Amst)       Date:  1985-03

6.  Memory and aging: the role of retrieval processes.

Authors:  D M Burke; L L Light
Journal:  Psychol Bull       Date:  1981-11       Impact factor: 17.737

7.  The effects and interactions of scopolamine, physostigmine and methamphetamine on human memory.

Authors:  S P Mewaldt; M M Ghoneim
Journal:  Pharmacol Biochem Behav       Date:  1979-02       Impact factor: 3.533

8.  Interaction of choline and scopolamine in human memory.

Authors:  R C Mohs; K L Davis
Journal:  Life Sci       Date:  1985-07-15       Impact factor: 5.037

9.  Qualitative analysis of scopolamine-induced amnesia.

Authors:  E D Caine; H Weingartner; C L Ludlow; E A Cudahy; S Wehry
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

10.  A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease.

Authors:  B J Sahakian; R G Morris; J L Evenden; A Heald; R Levy; M Philpot; T W Robbins
Journal:  Brain       Date:  1988-06       Impact factor: 13.501

View more
  43 in total

1.  Muscarinic tone sustains impulse flow in the septohippocampal GABA but not cholinergic pathway: implications for learning and memory.

Authors:  M Alreja; M Wu; W Liu; J B Atkins; C Leranth; M Shanabrough
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

2.  M channel KCNQ2 subunits are localized to key sites for control of neuronal network oscillations and synchronization in mouse brain.

Authors:  E C Cooper; E Harrington; Y N Jan; L Y Jan
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

3.  Pharmacological modulation of behavioral and neuronal correlates of repetition priming.

Authors:  C M Thiel; R N Henson; J S Morris; K J Friston; R J Dolan
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

Review 4.  Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia.

Authors:  Carrie K Jones; Nellie Byun; Michael Bubser
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

5.  Comparison of the effects of Alzheimer's disease, normal aging and scopolamine on human transient visual evoked potentials.

Authors:  A T Smith; F Early; G H Jones
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  Differential effects of scopolamine and lorazepam on working memory maintenance versus manipulation processes.

Authors:  Miriam Z Mintzer; Roland R Griffiths
Journal:  Cogn Affect Behav Neurosci       Date:  2007-06       Impact factor: 3.282

7.  RU 41,656 does not reverse the scopolamine-induced cognitive deficit in healthy volunteers.

Authors:  A Patat; M J Klein; A Surjus; M Hucher; J Granier
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

8.  A comparison of the effects of scopolamine and diazepam on working memory.

Authors:  J M Rusted; P Eaton-Williams; D M Warburton
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

9.  Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB.

Authors:  B J Sahakian; A M Owen; N J Morant; S A Eagger; S Boddington; L Crayton; H A Crockford; M Crooks; K Hill; R Levy
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  Central Executive Dysfunction and Deferred Prefrontal Processing in Veterans with Gulf War Illness.

Authors:  Nicholas A Hubbard; Joanna L Hutchison; Michael A Motes; Ehsan Shokri-Kojori; Ilana J Bennett; Ryan M Brigante; Robert W Haley; Bart Rypma
Journal:  Clin Psychol Sci       Date:  2014-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.